BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3282444)

  • 1. Immunohistochemical characterization of a set of monoclonal antibodies to human neuron-specific enolase.
    Seshi B; True L; Carter D; Rosai J
    Am J Pathol; 1988 May; 131(2):258-69. PubMed ID: 3282444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoradiometric and immunohistochemical demonstration of neuron-specific enolase in experimental rat gliomas.
    Vinores SA; Marangos PJ; Bonnin JM; Rubinstein LJ
    Cancer Res; 1984 Jun; 44(6):2595-9. PubMed ID: 6722796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
    Krajewski S; Chatten J; Hanada M; Reed JC
    Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody HISL-19 as an immunocytochemical probe for neuroendocrine differentiation. Its application in diagnostic pathology.
    Krisch K; Buxbaum P; Horvat G; Krisch I; Neuhold N; Ulrich W; Srikanta S
    Am J Pathol; 1986 Apr; 123(1):100-8. PubMed ID: 3515956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The existence and neurobiological significance of neuronal and glial forms of the glycolytic enzyme enolase.
    Marangos PJ; Schmechel D; Zis AP; Goodwin FK
    Biol Psychiatry; 1979 Aug; 14(4):563-79. PubMed ID: 385064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of gamma-subunit of enolase, neuron-specific enolase, in human non-neuroendocrine tumors and derived cell lines.
    Påhlman S; Esscher T; Nilsson K
    Lab Invest; 1986 May; 54(5):554-60. PubMed ID: 3009968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptophysin. A new marker for pancreatic neuroendocrine tumors.
    Chejfec G; Falkmer S; Grimelius L; Jacobsson B; Rodensjö M; Wiedenmann B; Franke WW; Lee I; Gould VE
    Am J Surg Pathol; 1987 Apr; 11(4):241-7. PubMed ID: 3032010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
    Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical demonstration of neuron-specific enolase in neoplasms of the CNS and other tissues.
    Vinores SA; Bonnin JM; Rubinstein LJ; Marangos PJ
    Arch Pathol Lab Med; 1984 Jul; 108(7):536-40. PubMed ID: 6547318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical evidence for neuroendocrine differentiation in human breast carcinomas.
    Monaghan P; Roberts JD
    J Pathol; 1985 Dec; 147(4):281-9. PubMed ID: 3003310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histidine decarboxylase expression as a new sensitive and specific marker for small cell lung carcinoma.
    Matsuki Y; Tanimoto A; Hamada T; Sasaguri Y
    Mod Pathol; 2003 Jan; 16(1):72-8. PubMed ID: 12527716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical localization of neuron-specific enolase in the human hypophysis and pituitary adenomas.
    Asa SL; Ryan N; Kovacs K; Singer W; Marangos PJ
    Arch Pathol Lab Med; 1984 Jan; 108(1):40-3. PubMed ID: 6362613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemistry of synapsin I and synaptophysin in human nervous system and neuroendocrine tumors. Applications in diagnostic neuro-oncology.
    Smith TW; Nikulasson S; De Girolami U; De Gennaro LJ
    Clin Neuropathol; 1993; 12(6):335-42. PubMed ID: 8287627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of metastatic neuroblastoma in bone marrow biopsy specimens with an antibody to neuron-specific enolase.
    Crary GS; Singleton TP; Neglia JP; Swanson PE; Strickler JG
    Mod Pathol; 1992 May; 5(3):308-11. PubMed ID: 1495935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuron-specific enolase as a new tumor marker].
    Ariyoshi Y; Kato K; Ishiguro Y; Ota K; Sato T; Suchi T
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1744-53. PubMed ID: 6349546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The value of neuron specific enolase (NSE) in patients with brain tumors].
    Taomoto K; Kokunai T; Okuda T; Tamaki N; Matsumoto S; Hashimoto N
    No To Shinkei; 1987 Feb; 39(2):169-73. PubMed ID: 3828153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution of immunohistochemical methods to the study of central nervous system tumors].
    Rubinstein LJ
    Ann Pathol; 1986; 6(3):157-63. PubMed ID: 3535816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
    Epstein AL; Marder RJ; Winter JN; Fox RI
    J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of monoclonal antibodies to human neuron-specific enolase.
    Seshi B; Bell CE
    Hybridoma; 1985; 4(1):13-25. PubMed ID: 3967894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duodenal gangliocytic paraganglioma. An immunohistochemical and ultrastructural study and a hypothesis concerning its origin.
    Perrone T; Sibley RK; Rosai J
    Am J Surg Pathol; 1985 Jan; 9(1):31-41. PubMed ID: 2578747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.